Everus (ECG) Competitors $42.93 +2.69 (+6.69%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$45.00 +2.07 (+4.82%) As of 04:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ECG vs. TMHC, IBP, ROAD, IESC, GRBK, DFH, BBU, CCS, LGIH, and LMBShould you be buying Everus stock or one of its competitors? The main competitors of Everus include Taylor Morrison Home (TMHC), Installed Building Products (IBP), Construction Partners (ROAD), IES (IESC), Green Brick Partners (GRBK), Dream Finders Homes (DFH), Brookfield Business Partners (BBU), Century Communities (CCS), LGI Homes (LGIH), and Limbach (LMB). These companies are all part of the "construction" industry. Everus vs. Taylor Morrison Home Installed Building Products Construction Partners IES Green Brick Partners Dream Finders Homes Brookfield Business Partners Century Communities LGI Homes Limbach Everus (NYSE:ECG) and Taylor Morrison Home (NYSE:TMHC) are both mid-cap construction companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability, community ranking and valuation. Do analysts rate ECG or TMHC? Everus currently has a consensus price target of $63.33, indicating a potential upside of 47.52%. Taylor Morrison Home has a consensus price target of $77.86, indicating a potential upside of 35.52%. Given Everus' higher possible upside, equities research analysts clearly believe Everus is more favorable than Taylor Morrison Home.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Everus 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Taylor Morrison Home 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the media prefer ECG or TMHC? In the previous week, Everus had 4 more articles in the media than Taylor Morrison Home. MarketBeat recorded 31 mentions for Everus and 27 mentions for Taylor Morrison Home. Taylor Morrison Home's average media sentiment score of 0.62 beat Everus' score of 0.24 indicating that Taylor Morrison Home is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Everus 6 Very Positive mention(s) 5 Positive mention(s) 20 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Taylor Morrison Home 13 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in ECG or TMHC? Taylor Morrison Home received 476 more outperform votes than Everus when rated by MarketBeat users. However, 87.50% of users gave Everus an outperform vote while only 59.48% of users gave Taylor Morrison Home an outperform vote. CompanyUnderperformOutperformEverusOutperform Votes787.50% Underperform Votes112.50%Taylor Morrison HomeOutperform Votes48359.48% Underperform Votes32940.52% Is ECG or TMHC more profitable? Taylor Morrison Home has a net margin of 10.81% compared to Everus' net margin of 0.00%. Taylor Morrison Home's return on equity of 16.50% beat Everus' return on equity.Company Net Margins Return on Equity Return on Assets EverusN/A N/A N/A Taylor Morrison Home 10.81%16.50%10.16% Do institutionals & insiders have more ownership in ECG or TMHC? 95.2% of Taylor Morrison Home shares are owned by institutional investors. 0.2% of Everus shares are owned by insiders. Comparatively, 1.4% of Taylor Morrison Home shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has higher earnings & valuation, ECG or TMHC? Taylor Morrison Home has higher revenue and earnings than Everus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEverus$2.85B0.77$143.42MN/AN/ATaylor Morrison Home$8.36B0.70$883.31M$8.606.68 SummaryTaylor Morrison Home beats Everus on 11 of the 15 factors compared between the two stocks. Get Everus News Delivered to You Automatically Sign up to receive the latest news and ratings for ECG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ECG vs. The Competition Export to ExcelMetricEverusOperative builders IndustryConstruction SectorNYSE ExchangeMarket Cap$2.19B$6.45B$8.34B$18.90BDividend YieldN/A1.60%2.12%4.02%P/E RatioN/A6.3515.6632.86Price / Sales0.770.7270.0827.89Price / CashN/A7.6421.4017.52Price / BookN/A1.354.194.47Net Income$143.42M$854.81M$535.55M$1.02B7 Day Performance4.68%-2.29%0.92%0.73%1 Month Performance14.46%-5.85%63.99%-2.62%1 Year PerformanceN/A-23.27%78.73%4.59% Everus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ECGEverus2.1405 of 5 stars$42.93+6.7%$63.33+47.5%N/A$2.19B$2.85B0.007,600Gap UpTMHCTaylor Morrison Home4.3315 of 5 stars$57.27-0.6%$77.86+35.9%+2.5%$5.83B$8.36B6.923,000IBPInstalled Building Products4.6377 of 5 stars$168.04-0.3%$216.09+28.6%-30.7%$4.64B$2.94B18.6710,300Upcoming EarningsPositive NewsROADConstruction Partners3.1861 of 5 stars$80.60+1.0%$92.00+14.1%+70.0%$4.50B$1.99B75.333,790Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsIESCIES1.9899 of 5 stars$199.20-1.1%N/A+59.7%$3.99B$3.00B18.558,080Short Interest ↑News CoveragePositive NewsGap UpGRBKGreen Brick Partners3.1646 of 5 stars$57.96+0.7%$74.00+27.7%+5.9%$2.58B$2.10B7.53550Earnings ReportNews CoverageDFHDream Finders Homes3.5437 of 5 stars$22.99+1.2%$30.17+31.2%-37.9%$2.15B$4.45B7.511,210Positive NewsBBUBrookfield Business Partners3.7954 of 5 stars$21.61-0.4%$30.75+42.3%+16.0%$1.93B$40.62B-44.1016,000Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageCCSCentury Communities4.4686 of 5 stars$54.02-2.8%$101.33+87.6%-31.9%$1.66B$4.35B5.191,540Analyst RevisionHigh Trading VolumeLGIHLGI Homes3.6486 of 5 stars$59.25-0.3%$118.33+99.7%-40.5%$1.39B$2.20B7.10950Earnings ReportAnalyst ForecastAnalyst RevisionLMBLimbach2.5011 of 5 stars$92.05-0.8%$102.67+11.5%+117.5%$1.07B$518.78M41.841,650Upcoming EarningsShort Interest ↓Positive News Related Companies and Tools Related Companies TMHC Competitors IBP Competitors ROAD Competitors IESC Competitors GRBK Competitors DFH Competitors BBU Competitors CCS Competitors LGIH Competitors LMB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ECG) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Everus Please log in to your account or sign up in order to add this asset to your watchlist. Share Everus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ECG Stock Free ECG Stock Alerts